GSTP1 and neoplasm: Results of multivariate Cox analysis showed that patients with advanced tumours and patients harbouring the GSTP1 105ValVal genotype had 8.90- and 3.87-fold higher likelihood of presenting disease progression than those with localised tumours and harbouring the GSTP1 IleIle or Ile Val genotype, respectively.